Key result
Serial hs-TnT, NT-proBNP, and age differentiate T1MI, T2MI, and myocardial injury with ~0.76 AUC.
Why the study?
Cardiac troponin enables rapid diagnosis of acute T1MI, but its ability to differentiate acute myocardial injury or T2MI is limited.
Does a combination of serial cardiac necrosis (hs-TnT) and strain (NT-proBNP) biomarkers with age improve the discrimination of T1MI, T2MI, and acute myocardial injury in patients presenting with suspected acute myocardial infarction?
Cohort (n=165)
No
Does a combination of serial cardiac necrosis (hs-TnT) and strain (NT-proBNP) biomarkers with age improve the discrimination of T1MI, T2MI, and acute myocardial injury in patients presenting with suspected acute myocardial infarction?
Combining serial measurements of hs-TnT and NT-proBNP with age improves the early differentiation of type 1 MI, type 2 MI, and acute myocardial injury compared to cardiac necrosis or strain biomarkers alone.
Answers are grounded in this paper and cite their sources.
May support refined early differentiation of myocardial injury; hypothesis-generating and should not change practice without validation.
Background: While cardiac-specific troponin (cTn) allows for rapid diagnosis of acute type 1 myocardial infarction (T1MI), its performance to differentiate acute myocardial injury (AI) or type 2 myocardial infarction (T2MI) is limited. The objective was to combine biomarkers to improve discrimination of different myocardial infarction (MI) aetiologies. Methods: = 495 serial plasma samples at three time points (on admission, after 1 h and 3 h) from 57 NSTEMI (non-ST-elevation myocardial infarction), 18 AI, and 31 STEMI patients, as defined by fourth universal definition of MI (UDMI4) and 59 control individuals. We then applied linear mixed effects model to compare the kinetics of all molecules in these MI sub-types. Results: Established (cTnT, cTnI) and novel (cMyBP-C) cardiac necrosis markers failed in differentiating T1MI vs T2MI at early time points. All cardiac necrosis markers were higher in T1MI than in T2MI at 3 h after admission. Muscle-enriched miRNAs (miR-1 and miR-133a) were correlated with cardiac necrosis protein markers and did not offer better discrimination. Established cardiac strain marker NT-proBNP differentiated AI and T1MI at all time points but failed to discriminate T2MI from T1MI. However, the combination of NT-proBNP and cTnT along with age returned an overall AUC of 0.76 [95 % CI 0.67-0.84] for differentiating T1MI, T2MI and AI. Conclusions: Rather than using single biomarkers of myocardial necrosis, a combination of clinical biomarkers for cardiac necrosis (troponin) and cardiac strain (NT-proBNP) might aid in differentiating T1MI, T2MI and AI.
No takes yet. Share an insight, caveat, or question.
Schulte et al. (2022) conducted a cohort in Suspected acute myocardial infarction (STEMI, NSTEMI type 1, NSTEMI type 2, acute myocardial injury, or non-cardiac chest pain) (n=165). Serial measurements of combined hs-TnT, NT-proBNP, and age vs. Single biomarker signatures (hs-TnT with age, or NT-proBNP with age) was evaluated on Discrimination of NSTEMI type 1 (T1MI), NSTEMI type 2 (T2MI), and acute myocardial injury (AI) (AUC 0.76, 95% CI 0.67-0.84). Combining serial hs-TnT and NT-proBNP measurements with age achieved an overall AUC of 0.76 for differentiating T1MI, T2MI, and acute myocardial injury.
Synapse has enriched 10 related papers. Consider them for comparative context: